ARIAD PHARMACEUTICALS INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARIAD PHARMACEUTICALS INC for February 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 24 2014 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | A | 8.73 | 75,000 | 654,750 | 75,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 12,500 | 0 | 44,859 | 32.4 K to 44.9 K (+38.63 %) |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | WILSON WAYNE | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | WILSON WAYNE | Director | Grant | A | 0.00 | 12,500 | 0 | 100,500 | 88 K to 100.5 K (+14.20 %) |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 96,859 | 84.4 K to 96.9 K (+14.82 %) |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Radaelli Massimo | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Radaelli Massimo | Director | Grant | A | 0.00 | 12,500 | 0 | 80,500 | 68 K to 80.5 K (+18.38 %) |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | LAVIDAS ATHANESE | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | LAVIDAS ATHANESE | Director | Grant | A | 0.00 | 12,500 | 0 | 106,631 | 94.1 K to 106.6 K (+13.28 %) |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | LAMARCHE JAY R | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | LAMARCHE JAY R | Director | Grant | A | 0.00 | 12,500 | 0 | 427,205 | 414.7 K to 427.2 K (+3.01 %) |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | Senior VP, Chief IP ... | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | SVP, Commercial Ope ... | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Option Exercise | A | 0.00 | 261,000 | 0 | 261,000 |